CarlosRodriguez-GalindoMD

Pediatric Hematology & Oncology • Boston, MA

Associate Professor of Pediatrics, Boston Children's Hospital

Join to view full profile

Are you Dr. Rodriguez-Galindo?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 26 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
44 Binney St
SW350
Boston, MA 02115
Phone+1 617-632-4580

Fax+1 617-632-5710
Is this information wrong?

Summary

Dr. Carlos Rodriguez-Galindo, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Tennessee. He is affiliated with St. Jude Children's Research Hospital and is an Associate Professor of Pediatrics at Boston Children's Hospital.

Education & Training

Universidad de Barcelona Faculty of MedicineClass of 1986

Certifications & Licensure

TN State Medical License 1998 - 2024
MA State Medical License 2009 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2014

Clinical Trials

Carboplatin Plus Vincristine in Treating Children With Retinoblastoma Start of enrollment: 1996 Feb 01
Completed
Phase 2
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma Start of enrollment: 1997 Nov 01
Completed
Phase 2
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors Start of enrollment: 2003 Sep 01
Completed
Phase 1
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Start of enrollment: 2007 Nov 05
Completed
Phase 2
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2008 Dec 08
Active, not recruiting
Phase 3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Start of enrollment: 2009 Sep 21
Completed
Phase 1, Phase 2
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease Start of enrollment: 2010 Sep 01
Completed
Phase 1
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Start of enrollment: 2010 Oct 04
Active, not recruiting
Phase 1
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Jan 01
Completed
Phase 1
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Start of enrollment: 2011 May 01
Completed
Phase 1
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Start of enrollment: 2011 Mar 01
Completed
Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Start of enrollment: 2011 Dec 01
Completed
Phase 1
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas Start of enrollment: 2012 Sep 01
Withdrawn
Not Applicable
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Clofarabine for Langerhans in Pedi
Withdrawn
Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders Start of enrollment: 2015 May 01
Active, not recruiting
Phase 2
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma Start of enrollment: 2018 Mar 15
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Identification and characterization of stromal-like cells with CD207CD1aphenotype derived from histiocytic lesions - a perspective in vitro model for drug testing.
Śmieszek, A., Marcinkowska, K., Małas, Z., Sikora, M., Kępska, M., Nowakowska, B., Deperas, M., Smyk, M., Raciborska, A., Rodriguez-Galindo, C.> ;BMC Cancer. 2024 Feb 12
Strategies to promote sustainable care for children with cancer in Ukraine.
Nogovitsyna, Y., Kizyma, R., Yakimkova, T., Wise, P., Kacharian, A., Agulnik, A., Vivtcharenko, V., Bhakta, N., Rodriguez-Galindo, C.> ;The Lancet. Oncology. 2024 Mar 1
Understanding treatment recommendations at diagnosis of advanced cancer in pediatric oncology: The need to explore decision-making challenges globally.
Lisa M Force, Loyce Hlatywayo, Marta Salek, Manoo Bhakta, Miguel Bonilla, Erica C Kaye, Carlos Rodriguez-Galindo, Justin N Baker, Nickhill Bhakta, Inam Chitsike> ;Pediatric Blood & Cancer. 2024 Apr 1
A regional virtual case discussion forum in pediatric oncology: Experience of the Pediatric Oncology East and Mediterranean Group.
Noun, D., Obeid, A., Belgaumi, A., Sidhom, I., Jadiry, M., Al-Saeed, R., Khalifa, N., Trehan, A., Ghanem, K., AbdelHafeez, H., Saab, R., Rodriguez-Galindo, C., Jeha, S.> ;Pediatric Blood & Cancer. 2024 Mar 1
1 citations
Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine.
Marta Salek, Alexandra Mueller, Inna Alanbousi, Zuzanna Cepowska, Malgorzata Dutkiewicz, Julian Earl, Dmitry Evseev, Roman Kizyma, Khrystyna Kliuchkivska, Julia Kolodr...> ;The Lancet. Oncology. 2023 Dec 1
1 citations
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.
Kris Ann P Schultz, Murali Chintagumpala, Jin Piao, Kenneth S Chen, Rachana Shah, Robyn D Gartrell, Emily Christison-Lagay, Farzana Pashnakar, Jesse L Berry, Allison F...> ;EJC Paediatric Oncology. 2023 Dec 1
1 citations
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).
Murali Chintagumpala, Jin Piao, Dan Gombos, Patricia Chevez-Barrios, Lindsay Brock, Ira J Dunkel, Rima Jubran, Ann M Leahey, Jonathan Kim, Joan O'Brien, Carol L Shield...> ;Pediatric Blood & Cancer. 2024 Jan 1
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Emilia M Pinto, Cintia Fridman, Bonald C Figueiredo, Hector Salvador, Manuel R Teixeira, Carla Pinto, Manuela Pinheiro, Christian P Kratz, Cinzia Lavarino, Edith A M F...> ;HGG Advances. 2024 Jan 11
1 citations
Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis.
Bella S Ehrlich, Michael J McNeil, Linh T D Pham, Yichen Chen, Jocelyn Rivera, Carlos Acuna, Liz Sniderman, Firas M Sakaan, Alejandra Mendez Aceituno, Cesar A Villegas...> ;The Lancet. Oncology. 2023 Sep 1
2 citations
Effect of paediatric early warning systems (PEWS) implementation on clinical deterioration event mortality among children with cancer in resource-limited hospitals in ...
Asya Agulnik, Hilmarie Muniz-Talavera, Linh T D Pham, Yichen Chen, Angela K Carrillo, Adolfo Cárdenas-Aguirre, Alejandra Gonzalez Ruiz, Marcela Garza, Tania Maria Cond...> ;The Lancet. Oncology. 2023 Sep 1
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.
Raja Shaikh, Brent R Weil, Christopher B Weldon, Nan Chen, Wendy B London, Morgan Krush, Megan Anderson, Mark Gebhardt, Alanna J Church, Steven G DuBois, Yana Pikman, ...> ;Cancer Medicine. 2023 Jun 1
Outcomes of SARS-CoV-2 infection in 126 children and adolescents with central nervous system tumors.
Daniel C Moreira, Ibrahim Qaddoumi, Yichen Chen, Nickhill Bhakta, Guillermo L Chantada, Victor M Santana, Miguela A Caniza, Meenakshi Devidas, Kathy Pritchard-Jones, C...> ;Pediatric Blood & Cancer. 2023 Aug 1
3 citations
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Patrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, Jin Piao, Mark D Krailo, Nadia Chung, Lindsay Brock, Alexander J Towbin, Elizabeth B McCarville, Milton J Fi...> ;Pediatric Blood & Cancer. 2023 Jul 1
2 citations
Tackling Pediatric Low-Grade Gliomas: A Global Perspective.
Daniel C Moreira, Catherine G Lam, Nickhill Bhakta, Frederick A Boop, Jason Chiang, Thomas E Merchant, Carlos Rodriguez-Galindo, Amar Gajjar, Ibrahim Qaddoumi> ;JCO Global Oncology. 2023 Apr 1
An exploratory study of sleep habits in school-aged survivors of retinoblastoma.
Summer Chahin, Melanie Morse, Ibrahim Qaddoumi, Sean Phipps, Valerie McLaughlin Crabtree, Rachel C Brennan, Matthew W Wilson, Carlos Rodriguez-Galindo, Kathryn M Russe...> ;Sleep Medicine. 2023 Mar 1
Understanding hope at diagnosis: A study among Guatemalan parents of children with cancer.
Anneliese H Williams, Silvia Rivas, Lucia Fuentes, Ana Cáceres-Serrano, Gia Ferrara, Tegan Reeves, Federico Antillon-Klussmann, Carlos Rodriguez-Galindo, Jennifer W Ma...> ;Cancer Medicine. 2023 Apr 1
Interdisciplinary care of pediatric oncology patients: A survey of clinicians in Central America and the Caribbean.
Dylan E Graetz, Yichen Chen, Meenakshi Devidas, Federico Antillon-Klussmann, Ligia Fu, Karina Quintero, Soad L Fuentes-Alabi, Pascale Y Gassant, Erica C Kaye, Justin N...> ;Pediatric Blood & Cancer. 2023 May 1
7 citations
Pediatric Early Warning Systems (PEWS) improve provider-family communication from the provider perspective in pediatric cancer patients experiencing clinical deteriora...
Srinithya R Gillipelli, Erica C Kaye, Marcela Garza, Gia Ferrara, Mario Rodriguez, Dora Judith Soberanis Vasquez, Alejandra Mendez Aceituno, Federico Antillón-Klussman...> ;Cancer Medicine. 2023 Feb 1
1 citations
Psychosocial outcomes and quality of life among school-age survivors of retinoblastoma.
Melanie Morse, Kendra Parris, Ibrahim Qaddoumi, Sean Phipps, Rachel C Brennan, Matthew W Wilson, Carlos Rodriguez-Galindo, Kristin Goode, Victoria W Willard> ;Pediatric Blood & Cancer. 2023 Feb 1
1 citations
The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience.
Rawad Rihani, Sima Jeha, Mayse Nababteh, Carlos Rodriguez-Galindo, Asem Mansour, Iyad Sultan> ;Frontiers in Oncology. 2023 Jan 1
Cure4Kids: Two decades of knowledge transfer.
Daniel C Moreira, Hannah M Jones, Elizabeth Schaeffer, Andrew Wellman, Ana Shuler, Raul Ribeiro, Guillermo Chantada, Carlos Rodriguez-Galindo> ;Pediatric Blood & Cancer. 2022 Dec 1
10 citations
Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).
Ira J Dunkel, Jin Piao, Guillermo L Chantada, Anuradha Banerjee, Sherif Abouelnaga, Jeffrey C Buchsbaum, Thomas E Merchant, Meaghan M Granger, Rima F Jubran, Joanna L ...> ;Journal of Clinical Oncology. 2022 Nov 20
13 citations
Model for regional collaboration: Successful strategy to implement a pediatric early warning system in 36 pediatric oncology centers in Latin America.
Asya Agulnik, Alejandra Gonzalez Ruiz, Hilmarie Muniz-Talavera, Angela K Carrillo, Adolfo Cárdenas, Maria F Puerto-Torres, Marcela Garza, Tania Conde, Dora J Soberanis...> ;Cancer. 2022 Nov 15
1 citations
Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country.
Omar El Khatib, Yasser Yahya, Rami Mahfouz, Lama Hamadeh, Maya Basbous, Miguel R Abboud, Samar Muwakkit, Carlos Rodriguez-Galindo, Sima Jeha, Raya Saab> ;Pediatric Blood & Cancer. 2022 Nov 1
4 citations
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations.
Lauriane Lemelle, Tim Flaadt, Brice Fresneau, Antoine Moya-Plana, Beate Timmermann, Jelena Roganovic, Andrea Ferrari, Giulia Fichera, Ulrich M Lauer, Tal Ben-Ami, Domi...> ;Journal of Pediatric Hematology/oncology. 2023 May 1
Join now to see all

Press Mentions

Tennessee Hospital Welcomes First Ukraine Child Cancer PatientsMarch 23rd, 2022
Genetic Ancestry Provides Important Context for Understanding Global Diversity in Childhood LeukemiaJanuary 27th, 2022
When Children and Teens with Cancer Get COVID-19September 22nd, 2021
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

St. Jude Children's Research HospitalMemphis, Tennessee